| Literature DB >> 34980092 |
Narges Zandieh1, Mohsen Rezaei Hemami2, Ali Darvishi3, Seyed Mohammad Hasheminejad4, Zahra Abdollahi5, Maryam Zarei5, Ramin Heshmat6.
Abstract
BACKGROUND: This study aimed to evaluate the cost-effectiveness of vitamin D supplementation in preventing type 2 diabetes mellitus (T2DM) among Iranian adolescents.Entities:
Keywords: Cost-effectiveness; Diabetes management; National program; Vitamin D supplementation
Mesh:
Substances:
Year: 2022 PMID: 34980092 PMCID: PMC8722369 DOI: 10.1186/s12906-021-03474-0
Source DB: PubMed Journal: BMC Complement Med Ther ISSN: 2662-7671
Data related to The Probabilities, Costs and Expendituresa
| Descriptions | Values |
|---|---|
| The probability of vitamin D deficiency before starting the supplementation program [ | 76% |
| The probability of vitamin D sufficiency before starting the supplementation program [ | 24% |
| The probability of vitamin D deficiency after starting the supplementation program [ | 17.2% |
| The probability of vitamin D sufficiency after starting the supplementation program [ | 87.2% |
| The prevalence of diabetes incidence in people with vitamin D deficiency [ | 12.8% |
| The prevalence of diabetes incidence in people with adequate vitamin D levels [ | 7% |
| The costs of the 9 pearls of vitamin D for each student | 0.236–0.472USD |
| The costs of the training staff to perform or supervise the project | 0.25 USD |
| The total costs of a one-year national program of vitamin D supplementation | 0.499–0.72 USD |
| The 2018-adjusted costs of diabetes management for each patients during one year | 709 USD |
a The expenditure data in 2018 was calculated at a dollar exchange rate declared by Iran’s Central Bank
bAccording to Iran’s Central Bank reports, the inflation rates in 2017 was 9.6
Fig. 1The decision tree model diagram (vitamin D intervention vs. no intervention)
Results of Base Case Cost-effectiveness Analysis
| Strategy | Cost($) | Incr Cost($)a | Effb | Incr Eff c | ICER (USD / QALY) |
|---|---|---|---|---|---|
| No Intervention | 80.9968 | 23.60384 | 0.74061 | 0.0058 | 4071.25 |
| Vitamin D Supplementation | 57.39296 | 0 | 0.7464 | 0 |
aIncremental costs
b Effectiveness
c Incremental Effectiveness
Incr Cost and Incr Eff were about 23.60384 and 0.0058, respectively
Main Input Parameters of CEA Model
| Statistic variable | Base case | SD/(CI) | Distribution | Source |
|---|---|---|---|---|
| Cost of vitamin D therapy | 0.61 USD | ±0.12 USD | Gamma | * |
| Cost of diabetes | 710 USD | ±70 USD | GAMMA | [ |
| Non-diabetes individual | 0.76 | Beta | [ | |
| Individual with diabetes disease | 0.59 | ±0.15 | Beta | [ |
* the Nutrition Improvement Office of the Ministry of Health
Fig. 2The incremental cost-effectiveness scatter plot (all samples are in the acceptable range)
Fig. 3The Monte Carlo Strategy Selection (100% vitamin D therapy is dominant)